DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Cote GM, Barysauskas CM, DeLaney TF. et al.
A Phase 1 Study of Nilotinib Plus Radiation in High-Risk Chordoma.
Int J Radiat Oncol Biol Phys 2018;
102 (05) 1496-1504
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.